Delaware Court Trims Tesla Director Settlement Fees

Delaware-incorporated public companies get a clearer rule that returned stock options do not count toward plaintiff fee awards.

Updated on Nov. 3, 2026 in Public Companies

Isometric editorial illustration of plain metal discs stacked beside a dark block on a pale surface, evoking a reduction in settlement value.
The Delaware Supreme Court on January 30, 2026 cut the Tesla director settlement attorneys' fee award from $173 million to $71 million, ruling forfeited options do not count as entity benefit. AI Illustration. Upload story photo >

The Delaware Supreme Court sitting en banc affirmed the settlement resolving excess compensation claims against Tesla's non-employee directors but cut the attorneys' fee award from $173 million to $71 million on January 30, 2026. The ruling matters to Delaware-incorporated companies because it limits how stock options returned for cancellation can be counted in fee calculations.

Why it matters

The court held that the forfeited options were not an entity-level recovery, narrowing the benefit that counts toward plaintiff attorneys' fees in derivative suits. Companies and boards in Delaware face a clearer boundary on what settlement value can be credited to the corporation when calculating litigation exposure.

The fee award was reduced from $173 million to $71 million against an overall settlement valued at $734 million, of which $458 million was unexercised stock options and $296 million was cash and stock. Approximately three million unexercised options were returned for cancellation by the director defendants.

The players

Tesla, Inc.

Tesla is a publicly traded electric vehicle and energy company whose board compensation was the subject of the excess compensation litigation.

Delaware Supreme Court

The state's highest court, which reviews Chancery Court decisions on corporate governance and fee awards in shareholder derivative litigation.

Court of Chancery

Delaware's specialized court of equity that handles most corporate governance and shareholder disputes, and which originally set the fee award.

The details

The defendants argued the Court of Chancery overvalued the settlement by counting the intrinsic value of unexercised options toward the financial benefit. The Delaware Supreme Court concluded that only benefits to the corporation belong in the benefit analysis under the general rule for derivative actions, so the forfeited options should not have been included in the valuation. Once those options were removed from the benefit calculation, the fee award fell substantially.

Timeline

  1. January 30, 2026: Delaware Supreme Court issued its decision modifying the fee award.

Market Landscape

The decision sits within Delaware's long-running oversight of director compensation and fee awards in shareholder derivative suits, where the Court of Chancery and Supreme Court set the terms for plaintiff recoveries. It refines how settlement value is measured, which shapes the economics of future excess-compensation challenges against public company boards.

Boards of Delaware-incorporated public companies should factor in that returned or forfeited equity is unlikely to count toward a plaintiff fee base, which may affect settlement strategy. Finance and legal teams should review how director equity grants are structured and documented, and consult qualified counsel before changing compensation practices.

The takeaway

The main operating lesson is that settlement value in Delaware derivative cases depends on what the corporation actually receives, not on the face value of options handed back. Boards should track how forfeited equity is characterized in any future settlement and consult qualified counsel on how the ruling applies to their own compensation programs.

Further reading

For more on how these governance disputes play out for listed firms, see Public Companies coverage in our business section.

Source note: This article includes information reported by Aoshearman.